Matches in SemOpenAlex for { <https://semopenalex.org/work/W2021863439> ?p ?o ?g. }
Showing items 1 to 72 of
72
with 100 items per page.
- W2021863439 endingPage "AB101" @default.
- W2021863439 startingPage "AB101" @default.
- W2021863439 abstract "Background: Patients with unresectable pancreatic cancers have extremely poor prognosis. The ineffective anti-cancer drugs, which cause adverse effect alone, should not be given to the patient with this dismal disease. It is an urgent investigational subject to predict the effectiveness of anti-cancer agent against pancreatic cancer prior to treatment. We examined the usefulness of Focused DNA Array (FDA) analysis using the pancreatic cancer tissue obtained by endoscopic ultrasound-guided fine-needle aspiration biopsy (EUS-FNA) for the prediction of chemotherapeutic effect. Methods: Tissues from 21 unresectable pancreatic cancers were obtained by EUS-FNA using the 19 or 22-gauge needle. Total mRNA was harvested from each sample, and cDNA was composed by reverse transcription polymerase chain reaction (RT-PCR). Expression of RNA was evaluated using FDA which was restricted to 133 genes including drug-resistance related genes. The amount of RNA was expressed as the relative value to house keeping gene. Result: Gemcitabine (GEM) was given to 17 patients. One course of GEM regimen composed 1000 mg/m2 weekly administration for three weeks following one week rest. Eleven patients completed 3 courses or more of this regimen were divided into the following two groups. Three patients with PR and three patients with tumor marker reduction by 50% or more were classified as responders. The other five patients were classified as non-responders. By the FDA, we measured the mRNA expression of dCMP deaminase (DCD) and RRM1 genes, which may act as GEM-resistant factors, and deoxycytidine kinase (DCK) gene, which may act as GEM-sensitive factor. Our gene scoring was defined as following. When the mRNA amount was half or less in GEM-resistant factors or twice or more in GEM-sensitive factor, compared to the mean amount of corresponding mRNA in all 21 tissues, one point was added to the gene score. When the mRNA amount was twice or more in GEM-resistant factors or half or less in GEM-sensitive factor, one point was subtracted from the gene score. In six responders, four tumors showed +1 (gene score) and two did +2. In five non-responders, one tumor indicated −1, three did zero point, and one did +1. When the gene score of +1 or more point was defined as a predictive indicator for GEM-efficacy, the sensitivity, specificity and accuracy were 100%, 80% and 91%, respectively. Conclusion: The FDA chip is loaded with many other genes related to 5-fluorouracil, cisplatin, molecular targeting agents, and so on, besides GEM. The gene analysis using a sample taken by EUS-FNA might be useful to predict the chemothrapeutic efficacy for patients with unresectable pancreatic cancer." @default.
- W2021863439 created "2016-06-24" @default.
- W2021863439 creator A5016903737 @default.
- W2021863439 creator A5028746378 @default.
- W2021863439 creator A5029970515 @default.
- W2021863439 creator A5038660776 @default.
- W2021863439 creator A5046130283 @default.
- W2021863439 creator A5065581439 @default.
- W2021863439 creator A5074479460 @default.
- W2021863439 creator A5078761490 @default.
- W2021863439 creator A5085373987 @default.
- W2021863439 date "2007-04-01" @default.
- W2021863439 modified "2023-10-16" @default.
- W2021863439 title "Prediction of the Chemotherapeutic Efficacy for Advanced Pancreatic Cancer By Focused DNA Array Analysis Using Endoscopic Ultrasound-Guided Fine-Needle Aspiration" @default.
- W2021863439 doi "https://doi.org/10.1016/j.gie.2007.03.071" @default.
- W2021863439 hasPublicationYear "2007" @default.
- W2021863439 type Work @default.
- W2021863439 sameAs 2021863439 @default.
- W2021863439 citedByCount "0" @default.
- W2021863439 crossrefType "journal-article" @default.
- W2021863439 hasAuthorship W2021863439A5016903737 @default.
- W2021863439 hasAuthorship W2021863439A5028746378 @default.
- W2021863439 hasAuthorship W2021863439A5029970515 @default.
- W2021863439 hasAuthorship W2021863439A5038660776 @default.
- W2021863439 hasAuthorship W2021863439A5046130283 @default.
- W2021863439 hasAuthorship W2021863439A5065581439 @default.
- W2021863439 hasAuthorship W2021863439A5074479460 @default.
- W2021863439 hasAuthorship W2021863439A5078761490 @default.
- W2021863439 hasAuthorship W2021863439A5085373987 @default.
- W2021863439 hasConcept C121608353 @default.
- W2021863439 hasConcept C126322002 @default.
- W2021863439 hasConcept C141071460 @default.
- W2021863439 hasConcept C143998085 @default.
- W2021863439 hasConcept C2775934546 @default.
- W2021863439 hasConcept C2776170712 @default.
- W2021863439 hasConcept C2780210213 @default.
- W2021863439 hasConcept C2780258809 @default.
- W2021863439 hasConcept C2780390042 @default.
- W2021863439 hasConcept C2781413609 @default.
- W2021863439 hasConcept C71924100 @default.
- W2021863439 hasConceptScore W2021863439C121608353 @default.
- W2021863439 hasConceptScore W2021863439C126322002 @default.
- W2021863439 hasConceptScore W2021863439C141071460 @default.
- W2021863439 hasConceptScore W2021863439C143998085 @default.
- W2021863439 hasConceptScore W2021863439C2775934546 @default.
- W2021863439 hasConceptScore W2021863439C2776170712 @default.
- W2021863439 hasConceptScore W2021863439C2780210213 @default.
- W2021863439 hasConceptScore W2021863439C2780258809 @default.
- W2021863439 hasConceptScore W2021863439C2780390042 @default.
- W2021863439 hasConceptScore W2021863439C2781413609 @default.
- W2021863439 hasConceptScore W2021863439C71924100 @default.
- W2021863439 hasIssue "5" @default.
- W2021863439 hasLocation W20218634391 @default.
- W2021863439 hasOpenAccess W2021863439 @default.
- W2021863439 hasPrimaryLocation W20218634391 @default.
- W2021863439 hasRelatedWork W1985900325 @default.
- W2021863439 hasRelatedWork W2059464886 @default.
- W2021863439 hasRelatedWork W2081419234 @default.
- W2021863439 hasRelatedWork W2370615362 @default.
- W2021863439 hasRelatedWork W2372656475 @default.
- W2021863439 hasRelatedWork W2376347278 @default.
- W2021863439 hasRelatedWork W2378004999 @default.
- W2021863439 hasRelatedWork W2410090482 @default.
- W2021863439 hasRelatedWork W2966996237 @default.
- W2021863439 hasRelatedWork W3041653713 @default.
- W2021863439 hasVolume "65" @default.
- W2021863439 isParatext "false" @default.
- W2021863439 isRetracted "false" @default.
- W2021863439 magId "2021863439" @default.
- W2021863439 workType "article" @default.